Kairos Pharma Ltd.

0.92
-0.05 (-5.15%)
At close: Mar 28, 2025, 3:59 PM
1.00
8.53%
After-hours: Mar 28, 2025, 06:45 PM EDT

Kairos Pharma Ltd. Income Statement

Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a
Operating Income -1.71M -571K -1.94M -1.05M
Interest Income n/a n/a n/a n/a
Pretax Income -1.81M -1.05M -2.15M -1.05M
Net Income -1.81M -1.05M -2.15M -1.05M
Selling & General & Admin 1.47M 324K 1.66M 1.03M
Research & Development 82K 87K 183K 20K
Other Expenses 160K 160K 98K n/a
Operating Expenses 1.71M 571K 1.94M 1.05M
Interest Expense 98K 479K 202K 5.41K
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 1.71M 571K 1.94M 1.05M
Income Tax n/a n/a n/a n/a
Shares Outstanding (Basic) 10.38M 10.24M 12.84M 11.22M
Shares Outstanding (Diluted) 10.38M 10.24M 12.84M 11.22M
EPS (Basic) -0.17 -0.1 -0.17 -0.09
EPS (Diluted) -0.17 -0.1 -0.17 -0.09
EBITDA -1.55M -431K -1.88M -1.05M
Depreciation & Amortization 160K 160K 98K -58